PAHO / J.E. Cogan
The man with the orange shirt was once sick with dengue and as a result he is now more aware of the causes of the disease. He takes care that there is no standing water in the tires of his workshop so that no one else gets sick.
© Credits

Dengue and severe dengue


    Dengue is a mosquito-borne viral infection that is common in warm, tropical climates. Infection is caused by any one of four closely related dengue viruses (called serotypes) and these can lead to a wide spectrum of symptoms, including some which are extremely mild (unnoticeable) to those that may require medical intervention and hospitalization. In severe cases, fatalities can occur. There is no treatment for the infection itself but the symptoms that a patient experiences can be managed.

    Earlier this year, WHO listed dengue as a potential threat among ten diseases for 2019 and current outbreaks in many countries confirm this observation. Dengue epidemics tend to have seasonal patterns, with transmission often peaking during and after rainy seasons. There are several factors contributing to this increase and they include high mosquito population levels, susceptibility to circulating serotypes, favourable air temperatures, precipitation and humidity, all of which affect the reproduction and feeding patterns of mosquito populations, as well as the dengue virus incubation period. Lack of proactive control interventions and staff are some of the other challenges.


    Dengue is a self-limiting febrile illness with symptoms ranging from asymptomatic to severe. Symptoms of dengue may be observed around 4–10 days after the bite of an infected mosquito. Common symptoms are like that of the flu, with patients experiencing: 

    • fever 
    • headaches 
    • pain behind the eyes 
    • muscle and joint pain 
    • nausea/vomiting 
    • rash 
    • fatigue. 

    As the disease progresses, patients can also suffer from respiratory distress, bleeding from the nose and gums and have a rapid drop in blood pressure leading to shock. If left unmanaged, this can lead to death. Sound case management of dengue in hospitals has helped to reduce case fatality rates to less than 1% in most affected countries. 

    Dengue is increasing at a higher rate than any other communicable disease, with 400% increase over 13 years (2000–2013). Annual dengue incidence is estimated to be in the order of 100 million symptomatic cases a year, with another ~300 million asymptomatic infections. The greatest burden is seen in Asia (75%) followed by Latin America and Africa.  


    There are no specific vaccines or antiviral treatments against dengue fever. Use of paracetamol to bring down the fever is indicated. Aspirin and related non-steroidal anti-inflammatory drugs (NSAIs) such as ibuprofen should be avoided. 

    Recovery from infection by one dengue virus provides lifelong immunity against that particular virus serotype. However, this immunity confers only partial and transient protection against subsequent infection by the other three serotypes of the virus. Evidence points to the fact that sequential infection increases the risk of developing severe dengue. The time interval between infections and the particular viral sequence of infections may also be of importance. 

    The best way to prevent infection is to avoid being bitten by mosquitoes during daytime. Mosquitoes that commonly transmit dengue virus often live in and around the home and in the garden. People should: 

    • wear clothing that covers the body well (especially legs and feet);  
    • keep mosquitoes out of the house by placing insect screens over doors and windows;  
    • apply insect repellents according to the manufacturer’s label instructions;  
    • sleep under a net, even during the day; and 
    • take extra precaution to prevent transmission if a family member is infected by avoiding mosquito bites. 




    Our work


    All →
    Surveillance and control of arboviral diseases in the WHO African region: assessment of country capacities
    The growing threat and recent epidemics of Aedes-borne arboviral infections in Africa has put into question the adequacy of public health systems to control...
    Virtual Meeting of Regional Technical Advisory Group for dengue and other arbovirus diseases, New Delhi, India, 4-6 October 2021

    Dengue is fast emerging as a significant public health challenge in all Member States of the WHO South-East Asia Region except the Democratic People's...

    Laboratory testing for Zika virus and dengue virus infections: interim guidance

    Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic...